End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.4 CNY | +2.52% | -4.12% | +12.76% |
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 57 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.76% | 628M | - | ||
+5.48% | 3.86B | D+ | ||
+15.86% | 1.94B | B+ | ||
+29.71% | 1.16B | - | ||
+1.80% | 963M | D+ | ||
+38.91% | 688M | - | - | |
+46.92% | 654M | B- | ||
-13.98% | 611M | - | - | |
+33.43% | 581M | - | ||
+28.90% | 554M | - | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300758 Stock
- Ratings Anshan Hifichem Co., Ltd.